Location: New York, NY
CIK: 0001017645 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 13, 2025
Total Value: $3.331B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DLO | DLOCAL | 46,656,695 | $666M | 20.0% | — | — | CLASS A COM | G29018101 |
| XP | XP, INC | 25,517,733 | $479M | 14.4% | — | — | CL A | G98239109 |
| ALHC | ALIGNMENT HEALTHCARE | 24,287,227 | $424M | 12.7% | — | — | COM | 01625V104 |
| CHYM | CHIME | 19,208,760 | $387M | 11.6% | — | — | COM SHS CL A | 16935C109 |
| ALKT | ALKAMI | 11,991,480 | $298M | 8.9% | — | — | COM | 01644J108 |
| — | AKERO THERAPEUTICS | 5,733,989 | $272M | 8.2% | — | — | COM | 00973Y108 |
| CNTA | CENTESSA PHARMACEUTICALS | 9,681,818 | $235M | 7.0% | — | — | SPONSERED ADS | 152309100 |
| PHVS | PHARVARIS | 8,031,252 | $200M | 6.0% | — | — | COM | N69605108 |
| RVMD | REVOLUTION MEDICINES | 2,474,428 | $116M | 3.5% | — | — | COM | 76155X100 |
| BULL | WEBULL | 7,198,867 | $106M | 3.2% | — | — | ORD SHS | G9572D103 |
| RPRX | ROYALTY PHARMA | 1,500,000 | $52.92M | 1.6% | — | — | CL A | G7709Q104 |
| EWCZ | EUROPEAN WAX CENTER | 13,110,492 | $52.31M | 1.6% | — | — | CLASS A COM | 29882P106 |
| RSKD | RISKIFIED | 5,324,998 | $24.92M | 0.7% | — | — | SHS CL A | M8216R109 |
| ADAG | ADAGENE | 3,782,339 | $7.527M | 0.2% | — | — | ADS | 005329107 |
| ALMS | ALUMIS | 1,297,530 | $5.177M | 0.2% | — | — | COM | 022307102 |
| GROV | GROVE COLLABORATIVE | 2,474,859 | $3.712M | 0.1% | — | — | COM CL A | 39957D201 |